324 related articles for article (PubMed ID: 35414485)
21. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
Sim TF; Hattingh HL; Sherriff J; Tee LBG
Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
[TBL] [Abstract][Full Text] [Related]
22. A qualitative exploration of mental health services provided in community pharmacies.
Crespo-Gonzalez C; Dineen-Griffin S; Rae J; Hill RA
PLoS One; 2022; 17(5):e0268259. PubMed ID: 35551556
[TBL] [Abstract][Full Text] [Related]
23. The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic.
Ghibu S; Juncan AM; Rus LL; Frum A; Dobrea CM; Chiş AA; Gligor FG; Morgovan C
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574698
[TBL] [Abstract][Full Text] [Related]
24. Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.
Pojskic N; MacKeigan L; Boon H; Austin Z
Res Social Adm Pharm; 2014; 10(2):341-54. PubMed ID: 23816494
[TBL] [Abstract][Full Text] [Related]
25. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design.
Buss VH; Shield A; Kosari S; Peterson GM; Naunton M
Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556
[TBL] [Abstract][Full Text] [Related]
26. Perceptions of pharmacists' role in the health care team through student-pharmacist led point-of-care screenings and its future application in health care.
Bastianelli KMS; Nelson L; Palombi L
Curr Pharm Teach Learn; 2017; 9(2):195-200. PubMed ID: 29233403
[TBL] [Abstract][Full Text] [Related]
27. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
Paudyal V; Hansford D; Cunningham S; Stewart D
Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
[TBL] [Abstract][Full Text] [Related]
28. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California.
Vu K; Rafie S; Grindlay K; Gutierrez H; Grossman D
J Pharm Pract; 2019 Feb; 32(1):54-61. PubMed ID: 29096570
[TBL] [Abstract][Full Text] [Related]
29. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
Alzubaidi H; Saidawi W; Mc Namara K
Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
[TBL] [Abstract][Full Text] [Related]
30. Pharmacists' Perspectives on Prescribing and Expanding Access to Hormonal Contraception in Pharmacies in the United States.
Rafie S; Cieri-Hutcherson NE; Frame TR; Griffin B; Harris JB; Horlen C; Shealy K; Stein AB; Stone RH; Vest K; Westberg S; Yancey AM
J Pharm Pract; 2021 Apr; 34(2):230-238. PubMed ID: 31390938
[TBL] [Abstract][Full Text] [Related]
31. Perceptions of pharmacists' roles in the era of expanding scopes of practice.
Schindel TJ; Yuksel N; Breault R; Daniels J; Varnhagen S; Hughes CA
Res Social Adm Pharm; 2017; 13(1):148-161. PubMed ID: 27061142
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
33. The nature of conflict in community pharmacy - A pilot study of pharmacists' experiences during the COVID-19 pandemic.
Lam W; Mey A; King MA; Woods P
Res Social Adm Pharm; 2022 Jul; 18(7):3164-3173. PubMed ID: 34521587
[TBL] [Abstract][Full Text] [Related]
34. Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia.
Parajuli DR; Khanal S; Wechkunanukul KH; Ghimire S; Poudel A
Res Social Adm Pharm; 2022 Aug; 18(8):3453-3462. PubMed ID: 34810136
[TBL] [Abstract][Full Text] [Related]
35.
Patterson SM; Cadogan CA; Barry HE; Hughes CM
BMJ Open; 2022 Sep; 12(9):e064549. PubMed ID: 36137632
[TBL] [Abstract][Full Text] [Related]
36. Primary health care policy and vision for community pharmacy and pharmacists in Australia.
Dineen-Griffin S; Benrimoj SI; Garcia-Cardenas V
Pharm Pract (Granada); 2020; 18(2):1967. PubMed ID: 32477437
[TBL] [Abstract][Full Text] [Related]
37. An explanatory model of community pharmacists' support in the secondary prevention of cardiovascular disease.
Puspitasari HP; Costa DSJ; Aslani P; Krass I
Res Social Adm Pharm; 2016; 12(1):104-118. PubMed ID: 26001624
[TBL] [Abstract][Full Text] [Related]
38. Community pharmacist workflow: Space for Pharmacy-based Interventions and Consultation TimE study protocol.
Karia AM; Balane C; Norman R; Robinson S; Lehnbom E; Durakovic I; Laba TL; Joshi R; Webster R
Int J Pharm Pract; 2020 Oct; 28(5):441-448. PubMed ID: 32347607
[TBL] [Abstract][Full Text] [Related]
39. Community pharmacists' role in benzodiazepine supply in Ireland: a questionnaire of pharmacists' views and experiences.
Cadogan CA; Ryder SA
Int J Pharm Pract; 2015 Dec; 23(6):415-22. PubMed ID: 25756294
[TBL] [Abstract][Full Text] [Related]
40. A national survey of pharmacists and interns in Aotearoa New Zealand: provision and views of extended services in community pharmacies.
McDonald J; Morris C; Pledger M; Dunn P; Fa'asalele Tanuvasa A; Smiler K; Cumming J
BMC Health Serv Res; 2021 Oct; 21(1):1147. PubMed ID: 34688303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
